Lutein Supplementation May Improve Outcomes in Early AMD - Takeaways - MDSpire

Lutein Supplementation May Improve Outcomes in Early AMD

Meta-analysis found statistically significant improvements, with clearest benefits in early-stage disease

  • By

  • Andrea Surnit

  • May 5, 2026

  • 3 min

Share

  • 1

    Lutein supplementation improves macular pigment optical density and best-corrected visual acuity in early-stage age-related macular degeneration.

  • 2

    The systematic review analyzed nine randomized trials involving 860 patients, showing significant benefits of lutein compared to placebo.

  • 3

    Improvements in visual outcomes were statistically significant for early-stage AMD but not for late-stage or mixed-stage populations.

  • 4

    Longer supplementation duration and higher cumulative lutein exposure correlated with greater changes in visual outcomes.

  • 5

    The study highlights the need for longer follow-up to assess lutein's effects on AMD progression and long-term vision outcomes.

Original Source(s)

Lutein Supplementation May Improve Outcomes in Early AMD

  • by Andrea Surnit

  • May 5, 2026

Related Content

Vamikibart Shows Early Safety in Uveitic Macular Edema

Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven

Trends and Key Areas of Research in the Pathophysiology, Imaging, and Treatment of Type 3 Macular Neovascularization (MNV3) Associated with Age-Related Macular Degeneration (AMD)

Artificial intelligence framework for multi-pathology risk assessment from retinal fundus images: deep learning approach to 15-disease screening